The current valuation score of Emergent BioSolutions Inc is 9.29, ranking 24 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is -53.17, which is -121.24% below the recent high of 11.29 and -31.58% above the recent low of -69.96.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.